| Smoking during application | Non-smoking during application | OR | 95% CI |
---|---|---|---|---|
LHC Cases | 75 (55.6%) | 22 (27.5%) | 3.29* | 1.81-5.98 |
MPD | 10 (14.28%) | 5 (7.93%) | 1.93 | 0.56-6.98 |
MDS | 19 (24.05%) | 5 (7.93%) | 3.67* | 1.18-12.11 |
Leukaemia | 21 (25.92%) | 2 (3.33%) | 10.15* | 2.15-65.69 |
Lymphoma | 17 (20.07%) | 6 (9.37%) | 2.72* | 1.02-8.00 |
PcD | 8 (11.76%) | 4 (6.45%) | 1.93 | 0.49-8.14 |
Controls | 60 | 58 | Ref | Ref |